Clinical Trials Browser

Interventional × domatinostat × Dermatologic × Clear all

NCT04133948 2025-03-10

DONIMI

Phase 1/2 Completed

Melanoma

NCT04393753 2024-05-08

MERKLIN2

Phase 2 Completed

Carcinoma, Merkel Cell

NCT03278665 2022-02-04

SENSITIZE

Phase 1/2 Completed

Melanoma

NCT04874831 2021-11-18

Domatinostat in Combination With Avelumab in Patients With Treatment-naïve Metastatic Merkel Cell Carcinoma (MERKLIN 1)

Phase 2 Withdrawn

Carcinoma, Merkel Cell